A carregar...
Construction and evaluation of a novel humanized HER2-specific chimeric receptor
INTRODUCTION: The human epidermal growth factor receptor 2 (HER2) represents one of the most studied tumor-associated antigens (TAAs) for cancer immunotherapy. The monoclonal antibody (mAb) trastuzumab has improved the outcomes of patients with HER2+ breast cancer. However, a large number of HER2+ t...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4095682/ https://ncbi.nlm.nih.gov/pubmed/24919843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3674 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|